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Apoptosis is induced by various stresses generated from the extracellular and intracellular environments. The ﬁdelity of the cell
cycle is monitored by surveillance mechanisms that arrest its further progression if any crucial process has not been completed
ordamages aresustained, andthenthe cellswithproblems undergoapoptosis.Althoughthemolecular mechanismsinvolvedin
the regulation of the cell cycle and that of apoptosis have been elucidated, the links between them are not clear, especially that
between cell cycle and death receptor-mediated apoptosis. By using the HeLa.S-Fucci (ﬂuorescent ubiquitination-based cell
cycle indicator) cells, we investigated the relationship between the cell cycle progression and apoptotic execution. To monitor
apoptotic execution duringcell cycleprogression, weobserved the cellsafterinduction ofapoptosis withtime-lapse ﬂuorescent
microscopy. About 70% of Fas-mediated apoptotic cells were present at G1 phase and about 20% of cells died immediately after
cytokinesis, whereas more than 60% of etoposide-induced apoptotic cells were at S/G2 phases in random culture of the cells.
These results were conﬁrmed by using synchronized culture of the cells. Furthermore, mitotic cells showed the resistance to
Fas-mediated apoptosis. In conclusion, these ﬁndings suggest that apoptotic execution is dependent on cell cycle phase and
Fas-mediated apoptosis preferentially occurs at G1 phase.
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Apoptosis is a mechanism of cell death that is fundamental in
many biological phenomena, including morphogenesis and
maintenance of tissue homeostasis. Apoptosis is character-
ized by chromatin condensation, nuclear fragmentation, and
formation of membrane-enclosed vesicles called apoptotic
bodies, which are phagocytosed by other cells. Various
stresses generated from the extracellular and intracellular
environments induce apoptosis. Stimuli that trigger apoptosis
in mammalian cells can be summarized into two major
categories of apoptotic pathways: the extrinsic and intrinsic
pathways.
1–3 The extrinsic pathway occurs in response
to external signals. This is also referred to as the death
receptor pathway, as it is mediated by ligation of cell
surface death receptors to their cognate ligands. Ligation of
death receptors induces subsequent downstream signaling
through the initiator caspase-8 and/or caspase-10. Intrinsic
apoptotic signaling occurs in response to stimuli such
as DNA damage, growth factor withdrawal, and exposure
to certain chemotherapeutic agents, all of which result
in the release of cytochrome c and other pro-death factors
from the intermembrane space of the mitochondria and
subsequent downstream signaling through the initiator
caspase-9.
Fas/CD95 is a member of the tumor necrosis factor
receptor superfamily, and induces apoptosis through the
extrinsic pathway. The activation of Fas/CD95 by its speciﬁc
ligand, FasL/CD95L, induces apoptosis in susceptible target
cells.
4 After activation of Fas/CD95, the adapter protein, Fas-
associated protein with death domain (FADD), binds to the
death domain of Fas/CD95 and attracts procaspase-8 via its
death effector domain to the receptor complex, forming the
death-inducing signaling complex (DISC).
5–7 Upon DISC
formation, procaspase-8 is autolytically cleaved and activated
and, in turn, cleaves downstream caspases such as effector
caspase-3 and -7, leading to cleavage of cellular proteins and
DNA and to subsequence apoptotic cell death.
8 On the other
hand, etoposide (VP-16) is one of the most widely used
anticancer drugs, belonging to the family of DNA topoisome-
rase II inhibitors. Etoposide causes DNA double-strand
breaks through the formation of a cleavage complex contain-
ing DNA–drug–enzyme, and induces apoptosis through the
intrinsic pathway.
9
Cellcyclecheckpointsrestrainfurthercellcycleprogression
if a process has not been successfully completed or DNA
damage has been sustained.
10 Checkpoints operate to
prevent further DNA replication within S phase when the
replication complexes are stalled, to prevent entry into mitosis
when DNA replication is not completed, and to prevent
chromosome segregation when mitotic spindle assembly has
not been completed. DNA damage-induced checkpoints also
inhibit entry into S phase, progression through S phase, and
entry into mitosis.
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www.nature.com/cddisRecently, HeLa.S-Fucci (ﬂuorescent ubiquitination-based
cell cycle indicator) cells were established by Miyawaki
group,
11 which express monomeric Kusabira-Orange 2
(mKO2) and monomeric Azami-Green 1 (mAG1) fused to
the ubiquitination domains of Cdt1 and geminin, respectively,
to monitor the cell cycle progression in situ. As Cdt1 and
geminin are the direct substrates of SCF
Skp2 and APC/C
Cdh1
complexes, respectively, the level of Cdt1 is highest at G1
phase whereas geminin is prominent during S, G2, and M
phases.Therefore,thecellnucleiofHeLa.S-Fuccicellsduring
the cell cycle are labeled with orange of mKO2 fused to the
ubiquitination domain of Cdt1 in G1 phase and green of mAG1
fused to the ubiquitination domain of geminin in S, G2, and M
phases. The availability of the Fucci system for the analysis of
tumor biology and cell biology in relation to cell cycle
regulation has been reported.
12–16
It has been unclear whether the apoptotic events are
dependent on the cell cycle phase, because the available
methods are not sufﬁcient to monitor the apoptotic execution
in situ. Common protocols such as immunoblotting and ﬂow
cytometry have been applied to examine the cell cycle
progression and apoptotic events, which indirectly indicated
thecellcyclephaseofapoptoticcellsbyusingmarkerproteins
such as cyclins and Rb, and DNA contents.
17–24 However,
cyclinE,Rb,andcyclin-dependentkinase(CDK)inhibitorsare
substrates for caspases,
25–28 and DNA contents gradually
decrease during apoptotic execution. Furthermore, if the
cells were examined after synchronization using some
drugs that are toxic to cells, it is difﬁcult to distinguish
whether apoptosis is induced by apoptotic stimuli. Here we
used HeLa.S-Fucci cells to directly monitor the cell cycle
progression and determine the cell cycle phase of apoptotic
cells induced by the extrinsic and intrinsic pathways under
the time-lapse ﬂuorescent microscopy. Our results clearly
indicated that apoptotic execution is dependent on cell cycle
phase and Fas-mediated apoptosis preferentially occurs at
G1 phase.
Results
The ratio of cell cycle phase of normal cells after
apoptosis induction. The relationship between apoptosis
and the cell cycle remains unclear. Therefore, we set out to
analyze the cell cycle speciﬁcity of Fas-mediated and
etoposide-induced apoptotic execution using HeLa.S-Fucci
cells. First, we checked the sensitivities of HeLa.S-Fucci cells
to the treatment of an agonistic anti-Fas antibody and
etoposide. The viability of the cells treated with the anti-Fas
antibody decreased in a time-dependent manner accompa-
nying the activation of caspases and the cleavage of caspase
substrate (Figures 1a and b). The response to etoposide had
a time lag of about 12h for the apoptosis execution and
caspase activation (Figures 1c and d). To study the effects of
the agonistic anti-Fas antibody and etoposide on the cell
cycle progression, we observed HeLa.S-Fucci cells with
immunoﬂuorescent microscope at 24h after treatment
(Figure 2a). Total number of living cells, which attached on
the culture dish and showed spread shape, decreased as
compared with that of non-treated cells. Although the ratio of
the cells having red nuclei to the cells having green nuclei in
non-treated and the anti-Fas antibody-treated cells seemed
to be unchanged, the relative number of normal cells having
green nuclei signiﬁcantly increased after treatment with
etoposide, suggesting that etoposide-induced apoptosis
occurred in a cell cycle-dependent manner. To conﬁrm this,
cells showing normal morphology were counted and classi-
ﬁed into each cell cycle phase according to the criteria as
shown in Figure 2b. Cells treated with etoposide were
signiﬁcantly accumulated at S/G2/M phases with nuclei
labeled with green color, consistent with the pharmacological
action of etoposide that inhibits topoisomerase II, thereby
arrests the cells at S and G2 phases (Figure 2c). Additionally,
we noticed a slight decrease of cells at G1 phase accom-
panying an increase of cells at S/G2/M phases in the anti-Fas
antibody-treated cells, suggesting that the Fas-mediated
apoptosis preferentially occurs at G1 phase.
Figure 1 Time-course of apoptosis execution and caspase activation in
HeLa.S-Fucci cells.Cellswerecultured inthepresenceof0.5mg/mloftheagonistic
anti-Fasantibody(aand b)o r5 0mMetoposide(VP-16) (c andd) for 24h. (a andc)
Cells were observed with the time-lapse ﬂuorescence microscope at 15-min
intervals. Cell viability was assessed morphologically at each time point on the
monitor of computer by counting ﬂat and well-attached cells as viable cells, and
shrunk or fragmented cells as dead cells. At least 200 cells were counted for each
measurement in all experiments. The data (mean±S.D.) were obtained from at
least three independent experiments. (b and d) Cell lysates were subjected to
SDS PAGE and immunoblotted with the antibodies as indicated
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Cell Death and DiseaseTime-lapse observation of Fas-mediated or etoposide-
induced apoptosis. To monitor the apoptotic execution
during cell cycle progression, we observed HeLa.S-Fucci
cells for 24h after treatment without or with the agonistic anti-
Fas antibody or etoposide with time-lapse ﬂuorescent
microscopy (see Supplementary Movies S1–S3), and the
typical features of the cells at 6h after treatment with the anti-
Fas antibody (Figure 3a) and at 24h after treatment with
etoposide (Figure 3b) were shown. Apoptotic cells with red
color were marked with red arrows, apoptotic cells with green
color were with green arrows, apoptotic cells with both red
and green colors were with yellow arrows, and apoptotic cells
without any color were with white arrows. Although most of
the cells treated with etoposide had green color, suggesting
that apoptotic cells were at S, G2, and M phases (Figure 3b),
the majority of Fas-mediated apoptotic cells had red color
indicating that the cells were dead at G1 phase (Figure 3a).
To conﬁrm this, we counted apoptotic cells and classiﬁed into
each cell cycle phase according to the criteria as shown in
Figure 4a. About 70% of apoptotic cells were present at G1
phase at 6h after treatment with the anti-Fas antibody, and
gradually decreased the apoptotic cells at G1 phase accom-
panying the increase of apoptotic cells at M/G1 phase (Figure 4b),
suggesting that Fas-mediated apoptosis preferentially occurred
at G1 phase. On the other hand, more than 60% of etoposide-
induced apoptotic cells had green color at 24h after treatment
with etoposide (Figure 4c), indicating that the etoposide-
induced apoptotic execution occurred at S/G2/M phases.
Figure 2 Effects of the treatment of the agonistic anti-Fas antibody or etoposide on cell cycle progression of HeLa.S-Fucci cells. (a) Cells were cultured in the absence
(upper panels) or the presence of 0.5mg/ml of the agonistic anti-Fas antibody (middle panels) or 50mM etoposide (VP-16) (lower panels) for 24h, and observed with
ﬂuorescence microscope. The morphology of the cells and the color of cell nuclei were shown by phase contrast, mKO2, mAG1, and merged images, respectively. Bars,
50mm. (b) The criteria for the classiﬁcation of normal HeLa.S-Fucci cells into each cell cycle phase. The ﬂattened cells with mKO2 were at G1 phase, the ﬂattened cells with
both mKO2 and mAG1 were at the border of G1 and S phases, the ﬂattened cells with mAG1 were at S and G2 phases, the smooth round cells with mAG1 were at M phase,
and the smooth round or ﬂattened cells without mKO2 nor mAG1 were at the transition from M to G1 phases. (c) The ratio of cell cycle phase of normal cells after apoptosis
induction. HeLa.S-Fucci cells were cultured as described in panel a. Cells showing normal morphology were counted and classiﬁed into each cell cycle phase according to
the criteria as shown in panel b. At least 100 cells were counted for each measurement in all experiments. The data (mean±S.D.) were obtained from at least three
independent experiments
Cell cycle-dependent Fas-mediated apoptosis
T Hashimoto et al
3
Cell Death and DiseasePreferential Fas-mediated apoptosis at G1 phase in
synchronized cells. To further examine the cell cycle-
dependent apoptotic execution, synchronized cells were
monitored under the time-lapse ﬂuorescent microscope
(Figure 5 and Supplementary Movies S4–S6) and the
numbers of normal, apoptotic, and mitotic cells were counted
on the photographs from each movie. Synchronized HeLa.S-
Fucci cells at the border of G1 and S phases transited
through M phase from 7 to 11h after the release to enter S
phase regardless of the presence or absence of the agonistic
anti-Fas antibody (Figure 5a), and the total number of cells
increased (Figure 5b), suggesting that the treatment of the
Figure 3 Effects of the treatment of the agonistic anti-Fas antibody or etoposide on the apoptotic execution of HeLa.S-Fucci cells. Cells were cultured in the presence of
0.5mg/mloftheagonisticanti-Fasantibody(a)or50mMetoposide(VP-16)(b)for24h,andwereobservedwithﬂuorescencemicroscope.Themorphologyofthecellsandthe
color of cell nuclei at 6h for Fas-treated cells (a) and at 24h for etoposide-treated cells (b) were shown by phase contrast, mKO2, mAG1, and merged images, respectively.
Apoptotic cells with mKO2 were marked with red arrows, apoptotic cells with both mKO2 and mAG1 were with yellow arrows, apoptotic cells with mAG1 were with green
arrows, and apoptotic cells without any ﬂuorescent proteins were with white arrows
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Cell Death and Diseaseanti-Fas antibody did not interfere with the cell cycle
progression from S to M phases. However, no mitotic cells
were observed in etoposide-treated synchronized cells
(Figure 5a), total number of the cells gradually decreased
(Figure 5b), and a large fraction of the cells had nuclei
labeling with green color (Supplementary Movie S6),
suggesting that etoposide-treated cells arrested at S and/or
G2 phases. The viability of synchronized cells treated with
the anti-Fas antibody decreased in a time-dependent
manner, but the prominent decrease was observed between
12 and 15h after the release to enter the cell cycle
(Figure 5c), indicating that the sensitivities of the cells to
the treatment with the anti-Fas antibody were transiently
enhanced after M phase. To conﬁrm these results, the
number of apoptotic cells per unit area was counted at each
time point (Figure 5d), and the increase of apoptotic cells at
each period was shown by the histogram (Figure 5e).
Apoptotic cells appeared at the highest level between 12
and 15h, suggesting that the Fas-mediated apoptosis was
preferentially executed at G1 phase. In contrast, the onset of
apoptotic execution of etoposide-treated cells was around
15h after treatment, and thereafter the decrease of viability
and the increase of apoptotic cells were observed in a time-
dependent manner (Figures 5f–h). These results suggested
that apoptotic execution is dependent on cell cycle phase
and Fas-mediated apoptosis preferentially occurs at G1
phase.
Resistance of mitotic cells to Fas-mediated apoptosis.
As shown in Figures 5a and e, Fas-mediated apoptosis was
transiently enhanced immediately after M phase. Further-
more, we noticed that there were no occurrence of apoptosis
during M phase under time-lapse ﬂuorescent microscope
observation of both asynchronous and synchronous cells
after induction of Fas-mediated apoptosis (Supplementary
Movies S2 and S5). These results suggest that mitotic cells
are resistant to Fas-mediated apoptosis. To conﬁrm this, we
counted mitotic cells on the movies and the images
constructing the movies, and classiﬁed into normal and dead
cells (Table 1). Cells treated with the agonistic anti-Fas
antibody normally transited through M phase, which have
more than 95% viability throughout the observation, even
though the total cell viability was gradually decreased. These
results strongly suggested that Fas-mediated apoptosis is
not executed during M phase.
FADD, a component of DISC, was suggested to be
phosphorylated at Ser-194in arrested cells at G2/M phases.
29
Therefore, we analyzed whether FADD is phosphorylated at
Ser-194 during M phase (Figure 6). After synchronization of
HeLa.S-Fucci cells at the border of G1 and S phases with a
double-thymidine block following its release into the cell cycle,
cells were collected at each time point and analyzed by
immunoblotting. Thedoubletbandsof FADDweredetectedat
8 and 10h after release from the thymidine block. Further-
more, the band corresponding to phosphorylated FADD was
detected with the antibody speciﬁcally recognized phosphory-
lated FADD at Ser-194 at the same periods. As synchronized
HeLa.S-Fucci cells at the border of G1 and S phases transited
through M phase from 7 to 11h after the release to enter S
phase as described in Figure 5, these results suggested that
FADD is phosphorylated at Ser-194 during M phase.
Discussion
The relationship between the apoptotic execution and the cell
cycle progressionhadbeendifﬁculttobeanalyzed,becauseit
Figure 4 Cell cycle dependency of the apoptosis execution in HeLa.S-Fucci
cellstreatedwiththeagonisticanti-Fasantibodyoretoposide.(a)Thecriteriaforthe
classiﬁcation of apoptoticHeLa.S-Fucci cells into each cell cycle phase. The shrunk
cells with mKO2 were at G1 phase, the shrunk cells with both mKO2 and mAG1
were at the border of G1 and S phases, the shrunk cells with mAG1 were at S, G2,
and M phases, and the shrunk cells with neither mKO2 nor mAG1 were at the
transition from M to G1 phases.HeLa.S-Fuccicells were cultured in the presence of
0.5mg/ml of the agonistic anti-Fas antibody (b)o r5 0mM etoposide (VP-16) (c) for
24h, and were observed with the time-lapse ﬂuorescence microscope at 15-min
intervals. Apoptotic cells were morphologically judged on the photographs and the
movies,andwerecountedand classiﬁedinto each cellcyclephase accordingto the
criteria as shown in panel a. At least 100 cells were counted for each measurement
in all experiments. The data (mean±S.D.) were obtained from at least three
independent experiments
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Cell Death and Diseasewas hard to determine the cell cycle phase of each apoptotic
cell. Here we determined the cell cycle phase of each
apoptotic cell by using HeLa.S-Fucci cells under time-lapse
ﬂuorescent microscope observation, and showed that Fas-
mediated apoptosis occurred preferentially at G1 phase
whereas etoposide-induced apoptosis did at S and G2
phases.
It was suggested that the cells treated with etoposide
arrested at S and/or G2 phases, as most normal and
apoptotic cells had nuclei labeled with green color and no
mitotic cells were observed (Figures 2–4, and Supplementary
Movies S3 and S6). As etoposide forms a complex with
topoisomerase II and DNA to enhance double-strand and
single-strand breaks and reversible inhibition of DNA religa-
tion, the cell cycle was arrested in S and/or G2 phases by
the mechanisms of the cell cycle checkpoints, leading to
apoptotic cell death through the intrinsic pathway before the
entry into M phase.
Fas-mediatedapoptosiswasexecutedthroughtheextrinsic
pathway of apoptosis. Although several groups tried to
Figure 5 Preferential apoptosis execution of HeLa.S-Fucci cells at G1 phase after treatment with the agonistic anti-Fas antibody. Cells were arrested at the border of G1
andSphasewithadouble-thymidineblock,followedbyreleasetoenterSphaseintheabsenceorpresenceof0.5mg/mloftheagonisticanti-Fasantibodyor50mMetoposide
(VP-16), and were observed with the time-lapse ﬂuorescence microscope at 15-min intervals (see Supplementary Movies S4–S6). (a) Mitotic cells showing smooth round
morphology with mAG1 were counted on the movies and were plotted over time. The plots showed the average number of mitotic cells from at least six ﬁelds. (b) Total cell
numberincludingnormal,apoptotic,andmitoticcellswerecountedonthemoviesandtheimagesconstructingthemovies.Theplotsshowedtheaveragenumberofcellsfrom
at least three ﬁelds. (c) Cell viability after treatment with the agonistic anti-Fas antibody was assessed morphologically on the movies and the images constructing the movies
by countingﬂat andwell-attached cells as viablecells,and shrunkor fragmentedcellsas dead cells. At least120 cellswerecountedfor eachmeasurement in onemovie. The
data(mean±S.D.)wereobtainedfromat leastsixmovies.(d)Theaveragenumberofapoptoticcellsper oneareaof0.58mm
2ateachtimepointwasobtainedfromthedata
in panel c.( e) A histogram showedthe average numberof apoptotic cells per one ﬁeld of 0.58mm
2. The data were obtainedfrom panel d.( f) Cell viability after treatment with
etoposide(VP-16)wasassessedmorphologicallyasdescribedinpanelc.(g)Theaveragenumberofapoptoticcellsperoneﬁeldof0.58mm
2ateachtimepointwasobtained
from the data in panel f.( h) A histogram showed the average number of apoptotic cells per one ﬁeld of 0.58mm
2. The data were obtained from panel g
Table 1 Resistance of mitotic cells to Fas-mediated apoptosis
Mitotic cells Total cells
Period (h) Normal Dead Total Viability (%)
a Viability (%)
b
0–6 133 2 135 98.5 98.7–82.8
6–12 143 1 144 99.3 82.8–78.8
12–18 127 3 130 97.7 78.8–70.7
18–24 177 9 186 95.2 70.7–61.4
Cell viability after treatment with the agonistic anti-Fas antibody was assessed
by counting cells on the movies and the images constructing the movies
aMitotic cells were classiﬁed into normal and dead cells during each period after
induction of Fas-mediated apoptosis. The data were obtained from six movies
bData were obtained from Figure 1a
Cell cycle-dependent Fas-mediated apoptosis
T Hashimoto et al
6
Cell Death and Diseasedetermine the cell cycle dependency of Fas-mediated
apoptosis, the results were inconsistent: more sensitive at
G1 phase,
17,21 no cell cycle dependency,
18,19 susceptible at S
phase,
20,30 and dependency at G1 and S phases.
22,23 Here
we clearly indicated that Fas-mediated apoptosis occurred
preferentially at G1 phase. Furthermore, we noticed that no
apoptosis occurred at M phase and the ratio of apoptotic cells
which died immediately after cytokinesis increased in a time-
dependent manner (Figure 4b and Supplementary Movies S2
and S5). These results suggest that mitotic cells show a
resistance to Fas-mediated apoptosis.
How are mitotic cells resistant to Fas-mediated apoptosis?
During mitosis, cells undergo dramatic changes including
chromosomal condensation, nuclear envelope breakdown,
and mitotic spindle formation. Phosphorylation events of
multiple proteins by CDKs and other mitotic kinases are
essential for the regulation of these processes.
31,32 The
components of DISC were suggested to be phosphorylated
during mitosis. FADD is the key adapter protein transmitting
apoptoticsignals mediated bythe deathreceptors.
5,7 FADDis
also implicated in cell proliferation, cell cycle progression,
tumor development, inﬂammation, innate immunity, and
autophagy.
33 Ser-194 of the FADD protein has been shown
to undergo phosphorylation in cells arrested in G2/M phases,
and three kinases able to phosphorylate FADD at the Ser-194
residue have been identiﬁed: the 37-kDa casein kinase Ia,
the 130-kDa Fas/FADD-interacting serine/threonine kinase
(FIST-HIPK3), and Polo-like kinase 1.
29,34–36 Furthermore,
the phosphorylation at Ser-203 of FADD by mitotic kinase
Aurora-A led to cooperative phosphorylation at Ser-194 of
FADD.
36 In contrast to pro-apoptotic cytoplasmic FADD, the
phosphorylation at Ser-194 is suggested to be essential for
the nuclear localization of FADD,
37 and nuclear FADD is
implicated in survival mechanisms.
38 As we detected the
phosphorylation at Ser-194 of FADD during M phase
(Figure 6), the molecular mechanisms of the resistance to
Fas-mediated apoptosis in mitotic cells may be partially
explained by the phosphorylation at Ser-194 of FADD that
sequestered FADD molecule in nuclei thereby preventing
DISC formation in the cytoplasm. Furthermore, phospho-
rylation at Ser-18 and Ser-21 of FADD during mitosis
were identiﬁed by phosphoproteomics analysis.
39 It will be
necessary to evaluate the possible contribution of these
phosphorylation of FADD to the regulation of Fas-mediated
apoptosis. On the other hand, it was recently reported that
procaspase-8 was phosphorylated in mitotic cells by Cdk1/
cyclin B1 on Ser-387, which prevented Fas-mediated apop-
tosis.
40 However, as the phosphorylated procaspase-8 at
Ser-387 was predominantly localized at centrosomes from
prometaphase to anaphase, further investigation will be
needed to clear the relationship between the phospho-
rylation of procaspase-8 at Ser-387 and the resistance of
mitotic cells to Fas-mediated apoptosis. Additionally, several
phosphorylation of the components of DISC during mitosis
was reported by phosphoproteomics analysis, such as
Ser-209, Ser-212, Thr-214, and Thr-219 of Fas/CD95,
41
Ser-276 and Ser-289 of procaspase-8.
39 The physiological
importance of the phosphorylation of these proteins in the
DISC formation needs to be clariﬁed.
Materials and Methods
Cell culture, synchronization, and apoptosis induction. HeLa.
S-Fucci cells
11 were cultured in DMEM supplemented with 10% fetal bovine serum
(FBS). For synchronization at the border of G1 and S phases, cells were seeded at
a density of 5 10
4 cells per 35-mm dish and cultured for 24h. After exposure to
2.5mM thymidine for 18h, cells were washed with phosphate-buffered saline
(PBS) three times and incubated in fresh medium for 10h, and then exposed to
2.5mM thymidine again for 14h. To release the cells from the arrest, medium
containing thymidine was removed, and the cells were washed with PBS three
times and incubated in fresh medium. For induction of apoptosis, cells were
treated with 0.5mg/ml of the agonistic anti-Fas antibody (CH-11; Medical &
Biological Laboratories, Nagoya, Japan) or 50mM etoposide (VP-16).
Immunoblot analysis. Cells were lysed in lysis buffer (20mM Tris-HCl
(pH 7.5), 150mM NaCl, 1% Nonidet P-40, 50mg/ml phenylmethanesulfonyl
ﬂuoride, 5mM EDTA). Protein samples were separated by SDS–polyacrylamide
gel electrophoresis and blotted onto Immobilon polyvinylidene diﬂuoride
membrane (Millipore, Billerica, MA, USA). Each protein was detected using
primary antibodies as indicated, horseradish peroxidase-conjugated secondary
antibodies, and ECL-plus detection reagent (GE Healthcare, Little Chalfont, UK).
Anti-caspase-3 polyclonal antibody (9662), anti-caspase-8 polyclonal antibody
(9764), anti-PARP polyclonal antibody (9542), and anti-phospho-FADD (Ser-194)
polyclonal antibody (2781) were obtained from Cell Signaling (Danvers, MA, USA);
anti-caspase-9 monoclonal antibody (M054-3), anti-FADD monoclonal antibody
(M033-3), and cyclin B1 monoclonal antibody (K0128-3) were from Medical &
Biological Laboratories; anti-caspase-7/MCH-3 monoclonal antibody (610812) was
from BD Biosciences (Rockville, MD, USA); anti-a-tubulin monoclonal antibody
(T6074) was from Sigma (St. Louis, MO, USA); anti-cyclin E monoclonal antibody
(sc-247) was from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Time-lapse ﬂuorescence microscopy. For time-lapse ﬂuorescence
microscopy, HeLa.S-Fucci cells were plated on a 35-mm dish. The medium
was replaced with MEM supplemented with 10% FBS without phenol red, and
dishes were placed in a humidiﬁed chamber at 371C that was mounted on a
ﬂuorescence microscope (model BZ-8000; Keyence, Osaka, Japan) with a
constant supply of mixed air containing 5% CO2. For analyses with BZ-8000, cells
were observed with a 20 X objective lens and image data were obtained
automatically every 15min from seven different ﬁelds by using BZ-H1TL software
(Keyence). In the original program by the manufacturer, cells are exposed to the
intense mercury lamp light intermittently and the cells were driven to apoptosis
within the initial 6h by the physical damage of the light. Therefore, we used the
neutral density ﬁlters to reduce the light levels to 1.6% that allowed the cells to
proliferate during 48h observation.
42
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Figure 6 FADD phosphorylation during mitotic HeLa.S-Fucci cells. Cells were
arrested at the border of G1 and S phases with a double-thymidine block, followed
by release to enter S phase. Cell lysates from cells at each time point were
subjected to SDS–PAGE, followed by immunoblotting with antibodies as indicated.
Cyclin B and cyclin E were used for cell cycle markers of G2/M and G1/S phases,
respectively
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